MentionFox
Home › Acquisitions › Beacon Topco, Inc.
Completed acquisition · SEC Form 8-K, Item 2.01

Barinthus Biotherapeutics plc. acquired by Beacon Topco, Inc.

Before you sign with, sell to or invest in Barinthus Biotherapeutics plc.

MentionFox check on Barinthus Biotherapeutics plc.: only 2 sources on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/acquisitions/beacon-topco-barinthus-biotherapeutics-2026-09-09

  • Note: Layoff plan disclosed Jan 2025 (filing)

New since last check: Layoff plan disclosed Jan 2025 (filing, first seen 14 November 2026).

Check Barinthus Biotherapeutics plc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Barinthus Biotherapeutics plc.?

From Barinthus Biotherapeutics plc.'s Form 8-K of 2026-09-09, quoted and linked below.

Barinthus Biotherapeutics plc. was acquired by Beacon Topco, Inc. on September 9, 2026, according to the Form 8-K Barinthus Biotherapeutics plc. filed with the SEC. The deal closed under a merger agreement dated September 29, 2025. It is the only completed acquisition Beacon Topco, Inc. reported under Item 2.01 in the last twelve months (Form 8-K, September 9, 2026).

2 companies announced an acquisition this week, 1 had other signals.

Companies in an acquisition this week, and the deal. Before you unlock: the company, the deal and what is inside. After: every way we found to reach the company, and anyone a source names. A team joining the buyer is labelled only when the filing itself says so.

InMed Pharmaceuticals Inc.agreed to acquire Mentari
Liberty Capital Corp/NVagreed to acquire Q Gateway Intermediate Holdings, LLC
Check one company free All companies that announced an acquisition this week

Competing with, selling to or investing in Beacon Topco, Inc. after this deal? See the free Snapshot first.

Free to see. No signup.

Beacon Topco, Inc. completed its acquisition of Barinthus Biotherapeutics plc. on 2026-09-09, according to the Form 8-K Barinthus Biotherapeutics plc. filed with the SEC on 2026-09-09. The filing's Item 2.01 states no aggregate dollar price. Barinthus Biotherapeutics plc. filed the report because the deal made it part of Beacon Topco, Inc..

AcquirerBeacon Topco, Inc.
AcquiredBarinthus Biotherapeutics plc.
Completed2026-09-09
Reported byBarinthus Biotherapeutics plc. (BRNS), the company acquired
FilingForm 8-K, filed 2026-09-09

Want the whole picture on Beacon Topco, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Beacon Topco, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Beacon Topco, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

What the filing says

On September 9, 2026 pursuant to a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006 (the " Scheme of Arrangement ") and as contemplated by the previously announced Merger Agreement, dated September 29, 2025 (the, " Original Merger Agreement "), as amended by that certain Amendment Agreement to the Merger Agreement dated February 22, 2026 (the " Merger Agreement Amendment "), by and among Barinthus Biotherapeutics plc (the " Company "), Beacon Topco, Inc. (" Topco "), Cdog Merger Sub, Inc (" Merger Sub ") and Clywedog Therapeutics, Inc (" Clywedog ") (together with the Original Merger Agreement, the " Merger Agreement "), the entire issued and to be issued share capital of the Company was acquired by Topco and the Company became a wholly-owned subsidiary of Topco (the " Transaction ").

More from the filing

This Current Report on Form 8-K is being filed in connection with the completion of the previously announced Transaction (as described below).
As previously announced, on September 1, 2026, the High Court of Justice of England and Wales (the " Court ") sanctioned the Scheme of Arrangement and a capital reduction of the share premium account of the Company.
On September 9, 2026, the Court Order was delivered to the Registrar of Companies in England and Wales, at which time the Scheme of Arrangement became effective (the " Scheme Effective Time ").

Quoted from Barinthus Biotherapeutics plc.'s Form 8-K.

This is the only completed acquisition Beacon Topco, Inc. reported under Item 2.01 in the last twelve months, as far as the filings of the companies it bought show.

Selling to Beacon Topco, Inc., or weighing an offer there?

Who runs it now, who owns it, where the money comes from and what to watch for, every claim linked to its source.

Order Full Report on Beacon Topco, Inc.
Not ready to order?

Look up Beacon Topco, Inc. first. Finding the company and seeing how much is on record uses no credits.

Look up Beacon Topco, Inc.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days of completing a significant acquisition or disposition of assets, under Item 2.01 of the report. The acquired company sometimes files one too, when the deal makes it a subsidiary of the buyer.

Every fact on this page is taken from one of those filings and linked to it: which company acquired which, the date the filing gives for completion, and the price when the filing states one in dollars, shown next to the sentence that states it. A filing states what was bought and on what terms; it rarely states why, and neither does this page.

More on Barinthus Biotherapeutics plc.

Cite this page

Permanent URL: https://mentionfox.com/acquisitions/beacon-topco-barinthus-biotherapeutics-2026-09-09
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2
Barinthus Biotherapeutics plc. acquired by Beacon Topco, Inc.: completed 2026-09-09. MentionFox, 2026-11-14. https://mentionfox.com/acquisitions/beacon-topco-barinthus-biotherapeutics-2026-09-09